Salivary Gland Diseases
Showing 26 - 50 of >10,000
Salivary Gland Cancer, Salivary Gland Tumors Trial in Novi Sad (Surgical intervention with or without postoperative adjuvant
Completed
- Salivary Gland Cancer
- Salivary Gland Neoplasms
- Surgical intervention with or without postoperative adjuvant therapy
-
Novi Sad, SerbiaClinic for maxillofacial surgery Clinical center of Vojvodina
May 22, 2022
Salivary Gland Tumor Trial in Philadelphia (MRI)
Recruiting
- Salivary Gland Tumor
- MRI
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Jun 19, 2022
Salivary Gland Carcinoma Trial in United States (Goserelin Acetate, Pembrolizumab)
Recruiting
- Salivary Gland Carcinoma
- Goserelin Acetate
- Pembrolizumab
-
Chicago, Illinois
- +6 more
Sep 22, 2022
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +35 more
- PI3K inhibitor BKM120
- cetuximab
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Sep 14, 2021
Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage IV Major Salivary Gland Cancer AJCC v8 Trial in
Recruiting
- Metastatic Salivary Gland Carcinoma
- +5 more
- Pembrolizumab
- Pemetrexed Disodium
-
Scottsdale, Arizona
- +2 more
Mar 15, 2022
Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in United States (Lenvatinib, Pembrolizumab)
Recruiting
- Adenoid Cystic Carcinoma
- Salivary Gland Cancer
-
Miami, Florida
- +7 more
Oct 26, 2022
Salivary Gland Carcinoma, Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in Boston (9-ING-41, Carboplatin)
Withdrawn
- Salivary Gland Carcinoma
- +3 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Feb 5, 2022
Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell
Active, not recruiting
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +29 more
- Cytology specimen
- Laboratory biomarker analysis
-
Philadelphia, PennsylvaniaThomas Jefferson University
Aug 31, 2021
Systemic Sclerosis Trial in Brest, Rennes, Tours (Minor Salivary gland Biopsy, ARFI, MSG US)
Completed
- Systemic Sclerosis
- Minor Salivary gland Biopsy
- +2 more
-
Brest, France
- +2 more
Apr 4, 2022
Head Neck Cancer Trial in Groningen (Submandibular Gland Stem Cell Transplantation)
Recruiting
- Head and Neck Cancer
- Submandibular Gland Stem Cell Transplantation
-
Groningen, NetherlandsUMCG
May 24, 2022
Malignant Salivary Gland Cancer, Salivary Gland Cancer Trial in Tampa, Chicago, Ann Arbor (APG-115, Carboplatin)
Recruiting
- Malignant Salivary Gland Cancer
- Salivary Gland Cancer
-
Tampa, Florida
- +2 more
Feb 10, 2022
Salivary Gland Cancer, Salivary Duct Carcinoma Trial in Nijmegen (68Ga-PSMA-PET/CT, 18FDG-PET/CT)
Recruiting
- Salivary Gland Cancer
- Salivary Duct Carcinoma
- 68Ga-PSMA-PET/CT
- 18FDG-PET/CT
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Aug 15, 2022
Head and Neck Squamous Cell Carcinoma, Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Recurrent Nasopharynx
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- +14 more
- Laboratory Biomarker Analysis
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 11, 2022
Salivary Gland Cancer, Metastatic, Advanced Trial in Toronto (Selinexor, EGFR or HER2 Inhibitor, FGFR Inhibitor)
Recruiting
- Salivary Gland Cancer
- +3 more
- Selinexor
- +6 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Feb 18, 2022
Xerostomia Due to Hyposecretion of Salivary Gland Trial in Cairo (Chamomile, Saline mouthwash)
Completed
- Xerostomia Due to Hyposecretion of Salivary Gland
- Chamomile
- Saline mouthwash
-
Cairo, EgyptAin Shams University
Nov 1, 2023
Salivary Gland Tumors Trial in Shanghai (Pyrotinib, Bicalutamide, Leuprorelin)
Recruiting
- Salivary Gland Neoplasms
- Pyrotinib
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Ton
Oct 8, 2021
Squamous Cell Head Neck Cancer, Radiation Induced Xerostomia, Salivary Hypofunction Trial run by the (AAV2hAQP1)
Recruiting
- Squamous Cell Head and Neck Cancer
- +2 more
- AAV2hAQP1
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
May 3, 2022
Salivary Gland Cancer, Recurrent Salivary Gland Cancer, Metastatic Cancer Trial in Boston (9-ING-41, Carboplatin)
Recruiting
- Salivary Gland Cancer
- +3 more
-
Boston, Massachusetts
- +1 more
Oct 15, 2021
Salivary Gland Dysfunction and Sjogren's Syndrome
Completed
- Lymphoma
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019
Salivary Gland Cancer Trial in Seoul (docetaxel plus Cisplatin)
Active, not recruiting
- Salivary Gland Cancer
- docetaxel plus Cisplatin
-
Seoul, Gangnamgu, Korea, Republic ofSamsung Medical Center
Aug 16, 2021
LSGB vs EMB in Diagnosis of Cardiac Transthyretin Amyloidosis
Not yet recruiting
- Amyloidosis
- Lip Salivary Gland Biopsy
-
London, Ontario, CanadaLondon Health Sciences Centre
May 16, 2022
Adenoid Cystic Carcinoma, Adenoid Cystic Carcinoma of the Salivary Gland Trial in Boston (Implantable Microdevice (IMD))
Not yet recruiting
- Adenoid Cystic Carcinoma
- Adenoid Cystic Carcinoma of the Salivary Gland
- Implantable Microdevice (IMD)
-
Boston, Massachusetts
- +1 more
Sep 22, 2022
Salivary Gland Cancer Trial in Cincinnati (Amivantamab)
Recruiting
- Salivary Gland Cancer
-
Cincinnati, OhioUniversity of Cincinnati Medical Center
Aug 5, 2022